June 10, 2020 / 12:56 PM / a month ago

BRIEF-Curis Announces FDA Clearance Of Ind Application For CI-8993

June 10 (Reuters) - Curis Inc:

* CURIS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR CI-8993, THE FIRST-IN-CLASS MONOCLONAL ANTI-VISTA ANTIBODY

* CURIS INC - PLANS TO INITIATE PHASE 1A/1B STUDY OF CI-8993 IN H2 OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below